CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 5, 2022 · earnings

RLMD earnings: a negative outcome, -7.7%

On May 5, 2022, RELMADA THERAPEUTICS, INC. reached its earnings. The result was a negative outcome, and the stock moved -7.7% in the window around the event. It had already run -13.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$24.27
1d before
$22.40
Event day
$21.23
1d after
$19.79
5d after

Pre-catalyst setup

-13.2%
30-day run-up
5303%
30-day volatility
1.0×
volume spike